findmyKOL
Clinical trialNCT01186068CompletedPhase 2Interventional

Dose Response Study of Patients With Erythematous Rosacea

SponsorVicept Therapeutics, Inc.Enrollment175Erythematous (Type One) Rosacea
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to evaluate the dose-response relationship (effect) of four concentrations of V-101 Cream in patients with erythematous(redness) rosacea.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Therapeutics Clinical Research

    San Diego, California, United States

  • Baumann Cosmetic & Research Institute

    Miami Beach, Florida, United States

  • Dermatology Specialists Research

    Louisville, Kentucky, United States

  • Dba Michigan Center for Skin Care Research

    Clinton Twp, Michigan, United States

  • Academic Dermatology Associates

    Albuquerque, New Mexico, United States

  • Oregon Medical Research Center, Pc

    Portland, Oregon, United States

  • Dermresearch, Inc.

    Austin, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

V-101
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Aug 2010
Primary completion
—
Completion
—
Last update posted
24 Nov 2010
Registered enrollment
175
Registry id
NCT01186068

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.